Accelerate to discover

Back to filter

Related topics

Quantitative evaluation of pulmonary function with hyperpolarized xenon gas MR

Bruker Biospin

Aug 20, 2020

Hyperpolarized 129Xe MR has been proven to be a powerful tool to evaluate the pulmonary function and has been widely...

Applications of Hyperpolarized 129Xe MRI for functional imaging of the lungs

Bruker Biospin

Aug 11, 2020

2015 marked the first ever translation of hyperpolarized gas MRI to diagnostic clinical practice. Research at the...

Micro-CT: Fancy gadget or indispensable technology towards quantification of lung diseases?

Bruker Biospin

Jul 29, 2020

Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...

Breakthrough discoveries from shear flow assays for Platelet biology and vascular studies

Fluxion Biosciences

Jul 17, 2020

After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...

Sep 24, 2020

Hybrid PET/MR enables exploration of new science

Bruker Biospin

Jul 14, 2020

Watch the recorded webinar on PET/MR, driven by Peter Caravan at MGH for the application part, during which the launch...

IncuCyte webinar: Advances in 3D cell models for cancer biology

Sartorius

Jul 1, 2020

Get answers to your questions on 3D spheroid-based drug discovery, organoid research and working with advanced cell...

MicroCT Applications in Lung research and Immunology

Bruker Biospin

Jun 22, 2020

The ability to monitore and quantitate lung disease in real time is an advantage to using small animal microCT. Also,...

Sep 24, 2020

Saphyr identifies all variants detected by the standard of care in cytogenetics

BioNano Genomics

Jun 1, 2020

Cancer genomics consortium members demonstrate 100% concordance between Bionano Genomics optical mapping technology and...

Show all topics (10)

Evaluating immunotherapeutic approaches for immuno-oncology using the iQue screener - June 17, 2016

Jun 13, 2016

Friday, June 17th, 2016, 5 pm CEST.

High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.

This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.

Register now

 

Webinar

Get more info

Riccardo Pasculli

Head of application support

Riccardo

Pasculli

+420 731 127 717

Send Message

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey